Oncology Impact Fund 2 (iCapital), L.P. — Form D/A
Oncology Impact Fund 2 (iCapital), L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2021-05-03. $129.3M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-05-03
- Form: D/A
- Accession: 0000897069-21-000202
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $129.3M
- Investors: 262
- Date of first sale: 2020-07-30
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-366990
Issuer
- Name: Oncology Impact Fund 2 (iCapital), L.P.
- CIK: 0001810465
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: C/O ICAPITAL PE GP, LLC, NEW YORK, NY, 10165
- Phone: (212) 994-7400
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| JUSTIN LIOI | Executive Officer | New York, NY |
| -- iCapital PE GP, LLC | Promoter | New York, NY |
Other filings by this issuer (1)
More